Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Avalon GloboCare Stock Quote

Avalon GloboCare (NASDAQ: AVCO)

$0.27
(-2.6%)
-$0.01
Price as of April 26, 2024, 3:46 p.m. ET

Avalon GloboCare Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AVCO -85.72% -99.03% -60.38% -96%
S&P +23.33% +73.48% +11.63% +131%

Avalon GloboCare Company Info

Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.